TrueWealth Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-395
Closed -$363K 51
2026
Q1
$363K Buy
395
+170
+76% +$172K 0.14% 42
2025
Q4
$242K Buy
+225
New +$215K 0.2% 45

Other funds holding LLY

TrueWealth Financial Partners's LLY Position: Q2 2026 in Review

TrueWealth Financial Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 395 shares — an estimated $363K sold.

TrueWealth Financial Partners first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $363K in Q1 2026. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TrueWealth Financial Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • TrueWealth Financial Partners sold 395 Eli Lilly shares in Q2 2026, an estimated $363K.
  • TrueWealth Financial Partners first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
  • TrueWealth Financial Partners's Eli Lilly position peaked at $363K in Q1 2026.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TrueWealth Financial Partners's 13F filing for Q2 2026, filed 13 Aug 2026.